Natallie Rocha

Reporter

Email: nrocha@sdbj.com
Phone: 858-277-6359 Extension: 3120

Recent Stories

Stemson Therapeutics Closes $15M Series A

BIOTECH: Co. Working on Genetic Therapy for Hair Loss

Stemson Therapeutics, a biotech company working on a cure for hair loss, closed a $15 million Series A funding round on July 15.

Tease photo

PerkinElmer Agrees to Acquire BioLegend

Deal worth approximately $5.25 billion

Wugen Secures $172M Series B

BIOTECH: Funding Backs Cell Therapy

Wugen, Inc. raised $172 million in Series B funding to advance its pipeline of off-the-shelf cell therapies for cancer. The oversubscribed financing will also help the Missouri-based biotech grow its presence in San Diego.

Tease photo

PacBio Acquires San Diego Startup Omniome

Pacific Biosciences will acquire San Diego-based Omniome in deal worth up to $800M

Tease photo

Poseida Partners with Cellares to Streamline Genetic Manufacturing

BIOTECH: Co. Gains Access to Cell Shuttle Technology

Poseida Therapeutics (Nasdaq: PSTX) announced a partnership with Bay-area start-up, Cellares Corporation to utilize its technology platform to accelerate cell manufacturing.

Stelios Therapeutics Acquired

Local biotech, Stelios Therapeutics, acquired by LEXEO Therapeutics

Avidity Biosciences CEO Reflects on Going Public in 2020

BIOTECH: Sarah Boyce Speaks About Completely Virtual IPO Process

The past year has changed everything about what it means for a biotech company to go public, according to Avidity Biosciences President and CEO Sarah Boyce.

Tease photo

Uqora Acquired by Pharmavite

BIOTECH: Co. Joins Maker of Nature Made

Pharmavite, the maker of Nature Made vitamins and supplements, acquired local life science company Uqora Inc. to expand its offerings of women’s health products.

Tease photo

Cortica, Inc. Secures $60 Million Series C Funding

HEALTHCARE: Co. Plans to Expand Autism Care Model

Cortica, Inc. secured $60 million in Series C funding to expand its technology-centered care model for children with autism and neurodevelopmental differences.

Tease photo

Ensysce Biosciences Closes SPAC Merger

BIOTECH: Latest Example of San Diego Life Science Cos. Going Public

Ensysce Biosciences is the latest local company to join the public market after closing the merger deal on July 1. The company will be trading its common stock on the Nasdaq under the ticker symbol “ENSC” and warrants under the ticker symbol “ENSCW” on the OTC Market.

More stories >>